Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01963676 · ClinicalTrials.gov registry record · NA
Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01963676: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT01963676 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01963676, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Investigating the effect of non-invasive transcranial current stimulation on auditory hallucinations in patients with schizophrenia. Normal neuronal activity is perturbed in schizophrenia, so selective targeting of this abnormal activity could serve as a treatment for schizophrenia and alleviate symptoms caused by abnormal neuronal activity, such as auditory hallucinations.
Primary Outcome
Examining AHRS total score after 5 days of stimulation compared to baseline assessment total.
Interventions
- DEVICE Sham stimulation
- DEVICE tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-10 |
| Phase | NA |
What the finished NCT01963676 record still lists
NCT01963676 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham stimulation is the first listed.
NCT01963676 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01963676 about?
NCT01963676 is a clinical study titled "Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia". Investigating the effect of non-invasive transcranial current stimulation on auditory hallucinations in patients with schizophrenia. Normal neuronal activity is perturbed in schizophrenia, so selective targeting of this abnormal activity could serve as a treatment for schizophrenia and alleviate sym...
What is the current status of trial NCT01963676?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2014-01. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01963676?
The interventions under investigation include: Sham stimulation (DEVICE), tDCS (DEVICE).
Who is sponsoring clinical trial NCT01963676?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01963676's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia